IDEAS home Printed from https://ideas.repec.org/a/wly/jpamgt/v31y2012i3p641-660.html
   My bibliography  Save this article

Does Targeted, Disease‐Specific Public Research Funding Influence Pharmaceutical Innovation?

Author

Listed:
  • Margaret E. Blume-Kohout

Abstract

No abstract is available for this item.

Suggested Citation

  • Margaret E. Blume-Kohout, 2012. "Does Targeted, Disease‐Specific Public Research Funding Influence Pharmaceutical Innovation?," Journal of Policy Analysis and Management, John Wiley & Sons, Ltd., vol. 31(3), pages 641-660, June.
  • Handle: RePEc:wly:jpamgt:v:31:y:2012:i:3:p:641-660
    as

    Download full text from publisher

    To our knowledge, this item is not available for download. To find whether it is available, there are three options:
    1. Check below whether another version of this item is available online.
    2. Check on the provider's web page whether it is in fact available.
    3. Perform a search for a similarly titled item that would be available.

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Hongxiu Li & Horatiu Rus, 2018. "Water Innovation and Water Governance: Adaptive Responses to Regulatory Change and Extreme Weather Events," Working Papers 1801, University of Waterloo, Department of Economics, revised Jan 2018.
    2. Graddy-Reed, Alexandra, 2020. "Getting ahead in the race for a cure: How nonprofits are financing biomedical R&D," Research Policy, Elsevier, vol. 49(8).
    3. David Popp, 2015. "Using Scientific Publications to Evaluate Government R&D Spending: The Case of Energy," CESifo Working Paper Series 5442, CESifo.
    4. Ke, Qing, 2020. "Technological impact of biomedical research: The role of basicness and novelty," Research Policy, Elsevier, vol. 49(7).
    5. Margaret E. Blume-Kohout, 2023. "The case of the interrupting funder: dynamic effects of R&D funding and patenting in U.S. universities," The Journal of Technology Transfer, Springer, vol. 48(4), pages 1221-1242, August.
    6. Kevin A. Bryan & Heidi L. Williams, 2021. "Innovation: Market Failures and Public Policies," NBER Working Papers 29173, National Bureau of Economic Research, Inc.
    7. David Popp, 2015. "Using Scientific Publications to Evaluate Government R&D Spending: The Case of Energy," NBER Working Papers 21415, National Bureau of Economic Research, Inc.
    8. Margaret K. Kyle, 2019. "The Alignment of Innovation Policy and Social Welfare: Evidence from Pharmaceuticals," NBER Chapters, in: Innovation Policy and the Economy, Volume 20, pages 95-123, National Bureau of Economic Research, Inc.
    9. Blume-Kohout, Margaret E. & Sood, Neeraj, 2013. "Market size and innovation: Effects of Medicare Part D on pharmaceutical research and development," Journal of Public Economics, Elsevier, vol. 97(C), pages 327-336.
    10. Kyle, Margaret K. & Ridley, David B. & Zhang, Su, 2017. "Strategic interaction among governments in the provision of a global public good," Journal of Public Economics, Elsevier, vol. 156(C), pages 185-199.
    11. Kalcheva, Ivalina & McLemore, Ping & Pant, Shagun, 2018. "Innovation: The interplay between demand-side shock and supply-side environment," Research Policy, Elsevier, vol. 47(2), pages 440-461.
    12. Margaret Blume-Kohout & Krishna Kumar & Christopher Lau & Neeraj Sood, 2015. "The effect of federal research funding on formation of university-firm biopharmaceutical alliances," The Journal of Technology Transfer, Springer, vol. 40(5), pages 859-876, October.
    13. Bhaven Sampat, 2022. "Second World War and the direction of medical innovation," WIPO Economic Research Working Papers 70, World Intellectual Property Organization - Economics and Statistics Division.
    14. Mikko Packalen & Jay Bhattacharya, 2018. "Does the NIH Fund Edge Science?," NBER Working Papers 24860, National Bureau of Economic Research, Inc.
    15. Yoshitsugu Kitazawa, 2012. "An improved theoretical ground for the linear feedback model and a new indicator," Discussion Papers 58, Kyushu Sangyo University, Faculty of Economics.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:wly:jpamgt:v:31:y:2012:i:3:p:641-660. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Wiley Content Delivery (email available below). General contact details of provider: http://www3.interscience.wiley.com/journal/34787/home .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.